{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:44:59Z","timestamp":1792622699790,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.cyto.2021.155511","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T01:29:22Z","timestamp":1617845362000},"page":"155511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["A novel inflammatory signaling pathway in patients with slow coronary flow: NF-\u03baB\/IL-1\u03b2\/nitric oxide"],"prefix":"10.1016","volume":"143","author":[{"given":"Neda","family":"Roshanravan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza Namazi","family":"Shabestari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naimeh Mesri","family":"Alamdari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Ostadrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7011-9507","authenticated-orcid":false,"given":"Ahmad","family":"Separham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezayat","family":"Parvizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Asghari","family":"Jafarabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid","family":"Ghodrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moloud","family":"Akbarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Naemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdiyeh Khabbaz Koche","family":"Ghazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samad","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cyto.2021.155511_b0005","first-page":"37","article-title":"The coronary slow flow phenomenon: characteristics, mechanisms and implications","volume":"1","author":"Wang","year":"2011","journal-title":"Cardiovasc. Diagn. Ther."},{"issue":"1","key":"10.1016\/j.cyto.2021.155511_b0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0002-8703(72)90307-9","article-title":"Angina pectoris and slow flow velocity of dye in coronary arteries\u2014a new angiographic finding","volume":"84","author":"Tambe","year":"1972","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.cyto.2021.155511_b0015","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1253\/circj.CJ-12-0205","article-title":"Defining the coronary slow flow phenomenon","volume":"76","author":"Beltrame","year":"2012","journal-title":"Circ. J."},{"issue":"4","key":"10.1016\/j.cyto.2021.155511_b0020","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1253\/circj.CJ-11-0959","article-title":"Coronary slow flow","volume":"76","author":"Hawkins","year":"2012","journal-title":"Circ. J."},{"issue":"4","key":"10.1016\/j.cyto.2021.155511_b0025","first-page":"118","article-title":"The coronary slow flow phenomena or \u201ccardiac syndrome Y\u201d: A review. Reviews","volume":"2","author":"Sharif-Yakan","year":"2014","journal-title":"Vasc. Med."},{"key":"10.1016\/j.cyto.2021.155511_b0030","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/383181","article-title":"Diverse spectrum of presentation of coronary slow flow phenomenon: a concise review of the literature","volume":"2012","author":"Chaudhry","year":"2012","journal-title":"Cardiol. Res. Pract."},{"issue":"3","key":"10.1016\/j.cyto.2021.155511_b0035","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ihj.2017.09.001","article-title":"Risk factors and angiographic profile of coronary slow flow (CSF) phenomenon in North Indian population: An observational study","volume":"70","author":"Mukhopadhyay","year":"2018","journal-title":"Indian Heart J."},{"issue":"2","key":"10.1016\/j.cyto.2021.155511_b0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00019501-200304000-00008","article-title":"Vascular endothelial function in patients with slow coronary flow","volume":"14","author":"Sezgin","year":"2003","journal-title":"Coron. Artery. Dis."},{"issue":"1","key":"10.1016\/j.cyto.2021.155511_b0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12325-008-0011-4","article-title":"Oxidative stress parameters in patients with slow coronary flow","volume":"25","author":"Enli","year":"2008","journal-title":"Adv. Ther."},{"key":"10.1016\/j.cyto.2021.155511_b0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","article-title":"Immune and inflammatory mechanisms of atherosclerosis","author":"Galkina","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155511_b0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cyto.2008.05.009","article-title":"The role of the chemokines MCP-1, GRO-\u03b1, IL-8 and their receptors in the adhesion of monocytic cells to human atherosclerotic plaques","volume":"43","author":"Papadopoulou","year":"2008","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cyto.2021.155511_b0060","first-page":"1","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target Ther."},{"issue":"3","key":"10.1016\/j.cyto.2021.155511_b0065","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jmb.2007.10.006","article-title":"Prevention of cardiac hypertrophy and heart failure by silencing of NF-\u03baB","volume":"375","author":"Gupta","year":"2008","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155511_b0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/1076029613498814","article-title":"Relationship between neutrophil to lymphocyte ratio and slow coronary flow","volume":"21","author":"Do\u011fan","year":"2015","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.cyto.2021.155511_b0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1076029615627340","article-title":"The relationship between lymphocyte-to-monocyte ratio and bare-metal stent in-stent restenosis in patients with stable coronary artery disease","volume":"23","author":"Murat","year":"2017","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"12","key":"10.1016\/j.cyto.2021.155511_b0080","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/ijcp.12495","article-title":"Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patients","volume":"68","author":"Gary","year":"2014","journal-title":"Int. J. Clin. Pract."},{"issue":"5","key":"10.1016\/j.cyto.2021.155511_b0085","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ahj.2004.05.016","article-title":"Impaired coronary blood flow in patients with metabolic syndrome: documented by Thrombolysis in Myocardial Infarction (TIMI) frame count method","volume":"148","author":"Turhan","year":"2004","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.cyto.2021.155511_b0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijcard.2005.09.007","article-title":"The relation between impaired glucose tolerance and slow coronary flow","volume":"111","author":"Binak","year":"2006","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.cyto.2021.155511_b0095","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: a quantitative method of assessing coronary artery flow","volume":"93","author":"Gibson","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2021.155511_b0100","doi-asserted-by":"crossref","first-page":"9168153","DOI":"10.1155\/2019\/9168153","article-title":"Clinical profile and outcome in patients with coronary slow flow phenomenon","volume":"2019","author":"Zhu","year":"2019","journal-title":"Cardiol. Res. Pract."},{"issue":"3","key":"10.1016\/j.cyto.2021.155511_b0105","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cyto.2021.155511_b0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"8","key":"10.1016\/j.cyto.2021.155511_b0115","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/MCA.0b013e32831381c8","article-title":"The correlation of thrombolysis in myocardial infarction frame count with insulin resistance in patients with slow coronary flow","volume":"19","author":"Ozcan","year":"2008","journal-title":"Coron. Artery. Dis."},{"issue":"5","key":"10.1016\/j.cyto.2021.155511_b0120","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ahj.2004.05.016","article-title":"Impaired coronary blood flow in patients with metabolic syndrome: documented by Thrombolysis in Myocardial Infarction (TIMI) frame count method","volume":"148","author":"Turhan","year":"2004","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.cyto.2021.155511_b0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0267659116659918","article-title":"Clinical and laboratory predictors of coronary slow flow in coronary angiography","volume":"32","author":"Ghaffari","year":"2017","journal-title":"Perfusion"},{"issue":"2","key":"10.1016\/j.cyto.2021.155511_b0130","first-page":"344","article-title":"Insulin resistance and vascular function","volume":"58","author":"Naruse","year":"2000","journal-title":"Nihon Rinsho"},{"issue":"4","key":"10.1016\/j.cyto.2021.155511_b0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/13813450903136791","article-title":"Contribution of insulin resistance to vascular dysfunction","volume":"115","author":"Anfossi","year":"2009","journal-title":"Arch. Physiol. Biochem."},{"issue":"10","key":"10.1016\/j.cyto.2021.155511_b0140","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2362.2004.01412.x","article-title":"Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance","volume":"34","author":"Doronzo","year":"2004","journal-title":"Eur. J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.cyto.2021.155511_b0145","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1161\/01.CIR.91.5.1314","article-title":"Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo","volume":"91","author":"Joannides","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2021.155511_b0150","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.HYP.29.1.280","article-title":"Relationship between insulin resistance and endothelium-dependent vascular relaxation in patients with essential hypertension","volume":"29","author":"Higashi","year":"1997","journal-title":"Hypertension"},{"issue":"15","key":"10.1016\/j.cyto.2021.155511_b0155","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1161\/01.CIR.101.15.1780","article-title":"Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance","volume":"101","author":"Balletshofer","year":"2000","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.cyto.2021.155511_b0160","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1253\/circj.67.1022","article-title":"Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow","volume":"67","author":"Camsarl","year":"2003","journal-title":"Circ. J."},{"issue":"3","key":"10.1016\/j.cyto.2021.155511_b0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1536\/ihj.46.373","article-title":"Plasma nitric oxide level and its role in slow coronary flow phenomenon","volume":"46","author":"Sezgin","year":"2005","journal-title":"Int. Heart J."},{"issue":"3","key":"10.1016\/j.cyto.2021.155511_b0170","first-page":"117","article-title":"Endothelial nitric oxide synthase gene polymorphisms in patients with slow coronary flow","volume":"9","author":"Sezgin","year":"2017","journal-title":"Interv. Med. Appl. Sci."},{"issue":"2","key":"10.1016\/j.cyto.2021.155511_b0175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2143\/AC.59.2.2005166","article-title":"Slow coronary flow may be a sign of diffuse atherosclerosis, Contribution of FFR and IVUS","volume":"59","author":"Pekdemir","year":"2004","journal-title":"Acta Cardiol."},{"issue":"Suppl 1","key":"10.1016\/j.cyto.2021.155511_b0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1590\/S0074-02762005000900002","article-title":"Nitric oxide as a regulator of inflammatory processes","volume":"100","author":"Wallace","year":"2005","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"3","key":"10.1016\/j.cyto.2021.155511_b0185","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1574-695X.2007.00329.x","article-title":"The role of nitric oxide in inflammatory reactions","volume":"51","author":"Tripathi","year":"2007","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155511_b0190","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22232","article-title":"Role of TLR4 and miR-155 in peripheral blood mononuclear cell-mediated inflammatory reaction in coronary slow flow and coronary arteriosclerosis patients","volume":"32","author":"Huang","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"issue":"6","key":"10.1016\/j.cyto.2021.155511_b0195","first-page":"56","article-title":"The association between inflammatory cytokines and miRNAs with slow coronary flow phenomenon","volume":"19","author":"Danaii","year":"2020","journal-title":"Iran J. Allergy Asthma Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2021.155511_b0200","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/0300060516664637","article-title":"Could neutrophil\/lymphocyte ratio be an indicator of coronary artery disease, coronary artery ectasia and coronary slow flow?","volume":"44","author":"Y\u0131lmaz","year":"2016","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"10.1016\/j.cyto.2021.155511_b0205","first-page":"37","article-title":"The coronary slow flow phenomenon: characteristics, mechanisms and implications","volume":"1","author":"Wang","year":"2011","journal-title":"Cardiovasc. Diagn. Ther."},{"issue":"2","key":"10.1016\/j.cyto.2021.155511_b0210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1385\/CT:5:2:183","article-title":"NF-kappaB in cardiovascular disease: diverse and specific effects of a \u201cgeneral\u201d transcription factor?","volume":"5","author":"Jones","year":"2005","journal-title":"Cardiovasc. Toxicol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155511_b0215","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1385\/CT:3:3:229","article-title":"NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling?","volume":"3","author":"Jones","year":"2003","journal-title":"Cardiovasc. Toxicol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155511_b0220","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbrc.2014.04.079","article-title":"Functional role of NF-\u03baB in expression of human endothelial nitric oxide synthase","volume":"448","author":"Lee","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"22","key":"10.1016\/j.cyto.2021.155511_b0225","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.2174\/13816128113196660752","article-title":"Regulation of endothelial nitric oxide synthase activity by protein-protein interaction","volume":"20","author":"Lee","year":"2014","journal-title":"Curr. Pharm. Des."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621000910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621000910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:59:15Z","timestamp":1760907555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466621000910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":45,"alternative-id":["S1043466621000910"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155511","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel inflammatory signaling pathway in patients with slow coronary flow: NF-\u03baB\/IL-1\u03b2\/nitric oxide","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155511"}}